Literature Alerts

LITERATURE ALERTS

• Characteristics of whispering-gallery-mode dye lasers utilizing dye-doped solid microspheres by UV N2-laser pumping. TANIGUCHI. H., and TANOSAKI, S., Opt. Quantum Electron., 1994, 26, (11), 1003–1210.
   Google Scholar
• Atomic energy-level shifts near a dielectric microsphere. JHE, Wand Kim, J. W., Phys. Rev. A. A. Mol. Opt. Phys., 1995, 51, (2), 1150–1153.
   PubMedGoogle Scholar
• Comparison of different separative techniques in the quantitative determination of active compound enclosed in liposomal systems. BONINA, F., MONTENEGRO, L., ROSA, C. LA, GASPARRI, F., and LEONARD, R., Int. J. Cosmet. Sci., 1994, 16, (5), 183–197.
   PubMedGoogle Scholar
• pH-sensitive release from poly(acrylamide-co-N,N'-methylenebisacrylamide) microspheres. YosH IzAwA, H., MIZUMA, Y., UEMURA, Y., KAwANo, Y., and HATATE, Y., y. Chem. Eng. Ypn, 1995, 28, (1), 46–52.
   Google Scholar
• Effect of calcium ions on the surface charge and aggregation of phosphatidylcholine liposomes. MOSHARRAF, M., TAYLOR, K. M. G., and CRAIG, D. Q. M.,Y. Drug. Targeting, 1995, 2, (6), 541–545.
   PubMedGoogle Scholar
• Generation of contrast-carrying liposomes of defined size with a new continuous high pressure extrusion method. SCHNEIDER, T., SACHSE, A., ROESSLING, G., and BRANDI., M., Int. J. Pharm., 1995, 117, (1), 1–12.
   Google Scholar
• Macromolecular prodrugs. IV. Alginate-chitosan microspheres of PHEA-L-dopa adduct. FILIPOVIC-GRCIC, J., MAYSINGER, D., ZORC, B., and JALsENjAK, I., Int. Y. Pharm., 1995, 116, (1), 39–44.
   Google Scholar
• pH-controlled silicone microspheres for controlled drug delivery. SUTINEN, R., LAASANEN, V., PARONEN, P., and URTT1, A., y. Controlled Release, 1995, 33, (1), 163–171.
   Google Scholar
• Microspheres as antigen carriers: studies on intestinal absorption and tissue localization of polystyrene microspheres in Atlantic salmon, Salmo salar L. DALMO, R. A., MCQUEEN-LEIFSON, R., and BOEGWALD, J., 1. Fish. Dis., 1995, 18, (1), 87–91.
   Google Scholar
• In vitro effects of brain-derived neurotrophic factor released from microspheres. MirrAL, S., COHEN, A., and MAYSINGER, D. NeuroReport, 1994, 5, (18), 2577–2582.
   PubMedGoogle Scholar
• Microencapsulation of somatotropic growth hormone. AISINA, R. B., DIOMINA, N. B., OVCHINNIKOVA, T. N., and VARFOLOMEYEV, S. D., STP Pharma. Sci., 1994, 4, (6), 437–441.
   Google Scholar
• Technological aspects in the microencapsulation of terbutaline-resin complexes. TORRES, D., BOADO, L., and VILA JATO, J. L., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 786–787.
   Google Scholar
• Diclofenac sodium microspheres: preparation and in vivo evaluation in rats. GURSOY, A., TURKOGLU, M., KALKAN, F., SARICA, O., AYDIN, S., and EROGLU, L., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 614–615.
   Google Scholar
• New cationic liposome vector of polynucleotides in gene therapy. PUYAL, C., MILHAUD, P., BIENVENUE, A., and PHILLIPOT, J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 595.
   Google Scholar
• Effects of free and liposome-encapsulated bisphosphonates on the cytokine secretion from activated macrophages. MONKKONEN, J., PENNANEN, N., LAPINJOKI, S., and URTTI, A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 256–157.
   Google Scholar
• Liposomal targeting of zidovudine. CHOW, D., and CHEN, G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 150–151.
   Google Scholar
• Phosphatidylinositolmannoside-based liposomes induce no synthase in primed mouse peritoneal macrophages. TENU, J.-P, SEKKAI, D., YAPO, A., PETIT, J. F., and LEMAIRE, G., Biochem. Biophys. Res. Commun., 1995, 208, (1), 295–301.
   PubMedGoogle Scholar
• Palmitoyl lysozyme-induced stabilization of PE (phosphatidylethanolamine) liposomes and their interaction with Candida albicans. LEE, E. O., and Kim, J. D.,9. Biochem.(Tokyo),1995, 117, (1), 54–58.
   Google Scholar
• Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions. BJOERK, E., ISAKSSON, U., EDMAN, P., and ARTURSSON, P., J. Drug Targeting, 1955, 2, (6), 501–507.
   Google Scholar
• Investigation on process parameters involved in polylactide-co-glycolide microspheres preparation. CONTI, B., GENTA, I., MODENA, T., and PAVANETTO, F., Drug. Dev. Ind. Pharm., 1995, 21, (5), 615–622.
   Google Scholar
• Use of surfactants in poly(lactic acid) protein microspheres. SORIANO, I., DELGADO, A., DIAZ, R. V., and EVORA, C., Drug. Dev. Ind. Pharm., 1995, 21, (5), 549–558. 0265-2048/95 $10.00 C) 1995 Taylor & Francis Ltd.
   Google Scholar
• Physical characterization of two types of microcrystalline cellulose and feasibility of microspheres by extrusion/spheronization. SONAGLIO, D., BATAILLE, B., TEROL, A., JACOB, M., PAUVERT, B., and CASSANAS, G., Drug Dev. Ind. Pharm., 1995, 21, (5), 537-547. Rifampicin-carrying poly(D, L-lactide) microspheres: loading and release. DENKBAS, E. B., KAITIAN, X., TUNCEL, A., and PISKIN, E., y. Biomater. Sc., Polym. Ed., 1995, 6, (9), 815-825. Preparation and chracterization of polystyrene microspheres surface-modified with glucoside moieties. SUGIYAMA, K., and OKU, T., Polym. y. (Tokyo), 1995, 27, (2), 179–188.
   Google Scholar
• Novel liposome-based multicomponent systems for the protection of photolabile agents. LOUKAS, Y. L., JAYASEKERA, P., and GREGORIADIS, G., Int. y. Pharm., 1995, 117, (I), 85–94.
   Google Scholar
• A study of 99m-technetium-labeled beclomethasone dipropionate dilauroylphosphatidyl-choline liposome aerosol in normal volunteers. VIDGREN, M., WALDREP, J. C., ARPPE, J., BLACK, M., RODARTE, J. A., COLE, W., and KNIGHT, V., Int. y. Pharm., 1995, 115, (2), 209–216.
   Google Scholar
• Disposition kinetics of liposomes modified with synthetic aminoglycolipids in rats. AOKI, H., SUN, C., FUJI, K., and MIYAJIMA, K., Int. y. Pharm., 1995, 115, (2), 183–191.
   Google Scholar
• Novel vaginal delivery systems for calcitonin: I. Evaluation of HYAFF/calcitonin microspheres in rats. RICHARDSON, J. L., RAMIRES, P. A., MIGLIETTA, M. R., ROCHIRA, M., BACELLE, L., CALLEGARO, L., and BENEDETTI, L., Int.J. Pharm., 1995, 115, (1), 9–15.
   Google Scholar
• Preparation and in vitro evaluation of magnetic microsphere-methotrexate conjugate drug delivery systems. DEVINENI, D., BLANTON, C. D., and GALLO, J. M., Bioconjugate Chem., 1995, 6, (2), 203–210.
   PubMedGoogle Scholar
• Hydrolysis of DMPC or DPPC by pancreatic phospholipase A2 is slowed down when (perfluoroalkyl)alkanes are incorporated into the liposomal membrane. PRIVITERA, N., NAON, R., and RIESS, J. G., Biochim. Biophys. Acta., 1995, 1254, (1), 1–6.
   PubMedGoogle Scholar
• Liposome-ibuprofen conjugate and the release characteristics of ibuprofen. SIVAKUMAR, P. A., MYTHILY, S., ALAMELU, S., and RAO, K., Indian Drugs, 1994, 31, (12), 568–572.
   Google Scholar
• Stability studies on primaquine diphosphate liposomes. ARICA, B., OZER, A. Y., and HINCAL, A. A., Hacettepe Univ. Eczacilik Fak. Derg., 1994, 14, (1), 39–48.
   Google Scholar
• Polyanhydride microspheres as potential vaccine delivery systems. CHIBA, M., HANES, J., and LANCER, R., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 877–878.
   Google Scholar
• Cholate induced disruption of calcitonin-loaded liposomes results in the formation of calcitonin-phospholipid complexes. ARIEN, A., TOULME, H. N., and DUPUY, B., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 792–793.
   Google Scholar
• Effect of derivatized pullulan-coated liposomes on the release of cytarabine in simulated GI fluids. SEHGAL, S., and ROGERS, J. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 788–789.
   Google Scholar
• Enhanced bioadhesion through surface degradation of polyanhydride microspheres. CHICKERING, D. E., JACOB, J. S., and MATHIOWITZ, E., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 776–777.
   Google Scholar
• Fluorinated liposomes: use of (F-alkyl)alkyl components to impart impermeability to the liposomal membrane. TREVINO, L., KRAFFT, M. P., FREZARD, F., GIULIERI, F., and RIESS, J. G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 606–607.
   Google Scholar
• Release kinetics of liposome-encapsulated ganciclovir in a rabbit model after intravitreal injection. BOURLAIS, C. LE, ACAR, L., ZIA, H., SADO, P. A., NEEDHAM, T., and LEVERGE, R., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 598–599.
   Google Scholar
• Liposomes and microspheres as controlled release systems for oligonucleotides. MENEGATTI, E., CORTESI, R., ESPOSITO, E., GAMBARI, R., and NASTRUZZI, C., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 596–597.
   Google Scholar
• Intestinal absorption of polymeric microspheres in the rat. DAMP, C., APRAHAMIAN, M., KOENIG, M., HOELTZEL, A., BALBONI, G., MARCHAIS, H., and BENOIT, J. P., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 577–578.
   Google Scholar
• Modulation of the pulmonary absorption of detirelix from liposomal formulations. BENNETT, D. B., and TIETELBAUM, Z., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 340–341.
   Google Scholar
• Studies on the optimization of loading and release kinetics of interferon-gamma from polylactide microspheres. CONWAY, B. R., ALPAR, H. O., and LEWIS, D. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 284–285.
   Google Scholar
• Treatment of solid tumors with liposomal vincristine: in vivo efficacy as a function of co-entrapped counterions. FORSSEN, E., Cox, G., COULTER, D. M., and PROFFITT, R. T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 154–155.
   Google Scholar
• Tolmetin poly-D, L-lactide microspheres: in vitro/in vivo evaluation. CONTI, B., Puousi, G., VENTURA, C. A., GIUNCHEDI, P., DONTE, U., CARUSO, A., and CUTULI, V., STP Pharma. Sci., 1994, 4, 269–274.
   Google Scholar
• Enhanced cellular response in mice treated with a Brucella antigen-liposome mixture. GALDIERO, F., CARRATELLI, C. R., Nuzzo, I., BENTIVOGLIO, C., MARTINO, L. DE, FOLGORE, A., and GALDIERO, M., FEMS Immunol. Med. Microbiol., 1995, 10, (3-4), 235–244.
   PubMedGoogle Scholar
• Development of dried liposome as effective immuno-adjuvant for hepatitis B surface antigen. Kim, C. K., and JEONG, E. J., Int. J. Pharm., 1995, 115, (2), 193–199.
   Google Scholar
• Efficacy, physical properties and pharmacokinetics of sterically-stabilized liposome-encapsu-lated hemoglobin. ZHENG, S., ZHENG, Y., BEISSINGER, R., and MARTIN, F. J., Arti f Cells, Blood Substitutes, Immobilization Biotechnol., 1994, 22, (3), 487–501.
   PubMedGoogle Scholar
• Microcapsules/microspheres related to chitosan. YAO, K. D., PENG, T., YIN, Y. J.,Xu, M. X., and GOOSEN, M. F. A., J. Macromol. Sci., Rev. Macromol. Chem. Phys., 1995, C35, (1), 155–180. Factors influencing the formation of hollow ceramic microspheres by water extraction of colloidal droplets. Liu, J. G., and WILuox, D. L. S., J. Mater. Res., 1995, 10, 84-94. Porous silica microcapsules. Kop MA, I., Seramikkusu, 1994, 29, (12), 1120–1122.
   Google Scholar
• Multilamellar liposomes including cholesterol as carriers of azobenzene disperse dyes in wool dyeing. DE LA MAZA, A., MANICH, A. M., CODERCH, L., and PARFtA, J. L., Text Res. y., 1995, 65, (3), 163–170. Wet expansion of microspheres. ANON. Res. Disci., 1994, 363, 349.
   Google Scholar
• Preparation of divinylbenzene homopolymeric microscapsules with highly porous mem-branes by in situ polymerization with solvent evaporation. YosHIZAWA, H., KujIKUito, K., UEMURA, Y., KAWANO, Y., KONDO, K., and HATATE, YChem. Eng. jpn, 1995, 28, (1), 78–84.
   Google Scholar
• Characteristics of cytotoxic T lymphocytes directed to influenza virus hemagglutinin elicited by immunization with muramyldipeptide-influenza liposome vaccine. liNumA, H., NEROME, K., YOSHIOKA, Y., and OKINAGA, K., Scand. J. Immunol., 1995, 41, (1), 1–10.
   PubMedGoogle Scholar
• Stromal changes in cancer. Studies on changes of stroma promoted by gastric cancerous cells using alginate microcapsules. SAKAI, Y., Nippon Ika Daigaku Zasshi, 1994, 61, (6), 548–555.
   PubMedGoogle Scholar
• Cell membrane lipids of wool and human hair form liposomes. KOERNER, A., PETROVIC, S., and HOECKER, H., Text Res. . 7., 1995, 65, (1), 56–58.
   Google Scholar
• Microencapsulation of DNA within alginate microspheres and crosslinked chitosan mem-branes for in vivo application. ALEXAKIS, T., BOADI, D. K., QUONG, D., GROBOILLOT, A., O'NEILL, I., PONCELET, D., and NEUFELD, R. T., Appl. Biochem. Biotechnol., 1995, 50, (1), 93–106.
   PubMedGoogle Scholar
• Flow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytes. McHuGH, T. M., Methods Cell Biol., 1994, 42, (Flow Cytometry (2nd Ed.), Pt. B), 575–595.
   Google Scholar
• Glow discharge treated PHEMA microspheres for albumin adsorption. DEN IZLI, A., and PisKIN, E., Turk. J. Chem., 1994, 18, (3), 188–196.
   Google Scholar
• A continuous fluorometric assay for phospholipases using polymerized mixed liposomes. Wu, S. K., and CHO, W., Anal. Biochem., 1994, 221, (1), 152–159.
   PubMedGoogle Scholar
• Effect of cholesterol fatty acyl chain composition and bilayer curvature on the interaction of cytochrome b5 with liposomes of phosphatidylcholines. TAYLOR, K. M. P., and ROSEMAN, M. A., Biochemistry, 1995, 34, (11), 3841–3850.
   Google Scholar
• Thermodynamics and volume compressibility of phosphatidylcholine liposomes containing bacteriorhodopsin. HIANIK, T., PIKNOVA, B., BUCKIN, V. A., SHESTIMIROV, V. N., and SHNYROV, V. L., Prog. Colloid, Polym. Sci., 1993, 93, 150–152.
   Google Scholar
• Vesicle-micelle structural transitions implicated in the interaction of liposomes composed of phosphatidylcholine and Triton X-100. DE LA MAZA, A., and PARRA, J. L., Comun. jorn. Corn. Esp. Deterg., 1994, 25, 477–492.
   Google Scholar
• An unusual temperature dependence of malondialdehyde formation in Fe2 /H202-initiated lipid peroxidation of phosphatidylcholine liposomes. Mist K, V., GERGEL, D., ALov, P., and ONDRIAS, K., Physiol. Res. (Prague), 1994, 43, (3), 163–167.
   Google Scholar
• Minus-end-directed motion of kinesin-coated microspheres driven by microtubule depoly-merization. Lommi.o, V. A., STEWART, R. J., and MCINTOSH, R. J., Nature (London), 1995, 373, (6510), 161–164.
   PubMedGoogle Scholar
• Reconstitution of plant membrane bound proteins into liposomes. KASAMO, K, Kagaku to Seibutsu, 1994, 32, (12), 797–810.
   Google Scholar
• Liposomal alpha-tocophero alleviates the progression of paraquat-induced lung damage. SUNTRES, Z. E., and SHEK, P. N., J. Drug Targeting, 1995, 2, (6), 493–500.
   PubMedGoogle Scholar
• Optimizing liposome-mediated gene transfer in primary rat septo-hippocampal cell cultures. YANG, K., FAUSTINELLA, F., XUE, J. J., WHITSON, J., KAMPFL, A., Mu, X. S., ZHAO, X., TAGLIALATELA, G., PEREZ, P. J. R., et al. Neurosci. Lett., 1994, 182, (2), 287–290.
   PubMed Web of Science ®Google Scholar
• Gene transfer and the expression of a foreign gene in vivo in post-mitotic neurons of the adult rate brain using the hemagglutinating virus of the Japan-liposome method. KATI:), K., YONEDA, Y., OKADA, Y., KIYAMA, H., and SHIOSAKA, S., Mol. Brain Res., 1994,25, (3-4), 359–363.
   PubMedGoogle Scholar
• Co-delivery to mammalian cells of a transcriptional factor with cis-acting element using cationic liposomes. FARHOOD, H., GAO, X., BARSOUM, J., and HUANG, L., Anal. Biochem., 1995, 225, (1), 89–93.
   PubMedGoogle Scholar
• Liposome-mediated CFT11 gene transfer to the nasal epithelium of patients with cystic fibrosis. CAPLEN, N. J., ALTON, E. W. F. W., MIDDLETON, P. G., DORIN, J. R., STEVENSON, B. J., GAO, X., DURHAM, S. R., JEFFERY, P. K., HODSON. M. E. etal. Nat. Med. (NY), 1995, 1, (1), 39–46.
   Google Scholar
• Lipid perturbation of liposomal membrane of dipalmitoyl phosphatidylcholine by chloroquine sulfate-a fluorescence anisotropic study. GHOSH, A. K., BASU, R., and NANDY, P., Colloids Surf. B, 1995, 4, (1), 1–4.
   Google Scholar
• Photoactivated enhancement of liposome fusion. BENNETT, D. E., and O'BRIEN, D. F., Biochemistry, 1995, 34, (9), 3102–3113.
   PubMedGoogle Scholar
• Evaluation of uniform-sized microcapsules using a vibration-nozzle method. SHIMANO, K., KONDO, O., MIWA, A., HIGASHI, Y KOYAMA, I., YOSHIDA, T., ITo, Y., HIROSE, J., and GOTO, S., Drug. Dev. Ind. Pharm., 1995, 21, (3), 331–347.
   Google Scholar
• Ethyl cellulose to prepare a matrix system of a hydrophilic drug by the microencapsulation process. VITKOVA, M., CHALABALA, M., RAK, J., and PROCHAZKA, R., STP Pharma. Sci., 1994, 4, (6), 486–491.
   Google Scholar
• Topical delivery of cyclosporin A from non-ionic liposomal systems: An in vivo/in vitro correlation study using hairless mouse skin. Hu, Z., NIEMIEC, S. M., RAMACHANDRAN, C., WALLACH, D. F. H., and WEINER, N., STP Pharma. Sci., 1994, 4, (6), 466–469.
   Google Scholar
• Effect of drug concentration in the monomer/crosslinker mixture on the loading levels and the release kinetics of non-steroidal anti-inflammatory drugs from ethylene glycol dimethacrylate cross-linked polyhydroxyethyl methacrylate microspheres. ORIENT,., SEGURINI, P., GIANASI, E., AIEDEH, K., CONTE, U., and ZECCHI, V., STP Pharma. Sci., 1994, 4, (6), 431–436.
   Google Scholar
• Uptake of alginate microspheres by Peyer's patches. BOWERSOCK, T. L., HOGENESCH, H., PARK, H., and PARK, K., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 839-840. Solvent influence in EC-microcapsules formation. PALOMO, M. E., BALLESTEROS, M. P., and FRUTOS, P., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 782–783.
   Google Scholar
• Microspheres for oral drug delivery from modified soybean protein. BARANTSEVICH, E., MILSTEIN, S., O'BROIN, B., PATON, D., SARUBBI, D., and GRECHANOVSK1, V., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 774–775.
   Google Scholar
• Spray-dried albumin microspheres containing carbamazepine. GIUNCHEDI, P., MAGGI, L., TORRRE, M. L., and CONTE, U., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 662–623.
   Google Scholar
• Optimization of interferon incorporation into liposomes and antiviral activity of liposomal interferon. TORCHILIN, V. P., LUKYANOV, A. N., ZOLIN, V. V., BIRIUKOVA, V. I., and KOLOKOLTCEV, A. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 602–603.
   Google Scholar
• Nicotine microspheres for transnasal delivery: loading and release characteristics. CORNAZ, A. L., and BURI, P., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 563–564.
   Google Scholar
• Incorporation of lipophilic drugs into liposomes from lipid-ethanol admixtures and compari-sons with conventional liposomes. CONSTANTINIDES, P. P., DENTIGER, P., and HUANG, L., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 501–502.
   Google Scholar
• /n vivo evaluation of camptothecin microspheres for targeted drug delivery. SONAVARIA, V. J., JAMBHEKAR, S., and MAHER, T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 194–195.
   Google Scholar
• Microspheres of dexamethasone as a biodegradable controlled release drug delivery system. CROSSAN, I. M., and WHATELEY, T. L., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 184–185.
   Google Scholar
• Preparation of salbutamol sulfate-poly(lactic-co-glycolic acid) microspheres by double emulsion method. ERDEN, N., and CELEBI, N., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 180–181.
   Google Scholar
• Microspheres from tyrosine-based polymers: evaluation of processing parameters and initial release data. KOHN, J., Yu, C., YEO, S. D., and DEBENEDETTI, P. G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 132–133.
   Google Scholar
• Drugs-in cyclodextrins-in liposomes: a novel concept in drug delivery. GREGORIADIS, G., and MCCORMACK, B., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 89–90.
   Google Scholar
• Synthesis of N-stearyl lactobionamide (N-SLBA) and preparation of neo4alactosylated Liposome. Km, C. K., MIN, M. H., MIN, K. H., LAH, W. R., LEE, B. J., and KIM. Y. B., Yakhak Hoechi, 1992, 36, (2), 159–166.
   Google Scholar
• Degradation and drug release characteristics of monosize poly(ethyl cyanoacrylate) micro-spheres. CICEK, H., TUNCEL, A., TuNCEL, M., and Pi SKIN, E.,Y Biomater. Sci. Polym. Ed., 1995, 6 (9), 845–856.
   PubMedGoogle Scholar
• Controlled release salbutamol sulfate microcapsules prepared by emulsion solvent-evaporation technique and study on the release affected parameters. AMPERIADOU, A., and GEORGARAKIS, M., Int. J. Pharm., 1995, 115, (1), 1–8.
   Google Scholar
• Evaluation of tableted microspheres of dipyridamole. Gu RSOY, A., TuRKOGLU, M., SENYUCEL, B., KALKAN, F., and OKAR, I., Drug Dev. Ind. Pharm., 1995, 21, (4), 503–507.
   Google Scholar
• Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells. LAPPALAINEN, K., URTTI, A., SOEDERLING, E., JAEAESKELAEINEN, I., SYRJAENEN, K., and SYRJAENEN, S., Biochim. Biophys. Acta, 1994, 1196, (2), 201–208.
   PubMedGoogle Scholar
• Spray-drying for the preparation of chitosan microspheres. GENTA, I., PAVANETTO, F., CONTI, B., GIUNCHEDI, P., and CONTE, U., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 616–617.
   Google Scholar
• Characterization of release behaviour of microcapsules loaded with xylene. MATHIAS, P. A., and THIES, C., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 812–813.
   Google Scholar
• Liposome protection in vivo with synthetic polymers other than polyethylene glycol. TORCHILIN, V. P., MILSTEIN, A. M., and SEITILMAN, M. I., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 604–605.
   Google Scholar
• pH-dependent pore formation in liposomes: an approach to triggered release. WHEATLEY, M. A., ALFORD, D., and HSIAO, C. Y. S., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 600–601.
   Google Scholar
• Preparation and characterization of cisplatin-loaded PBLG microspheres for chemoemboliza-tion. Li, C., YANG, D. J., KUANG, L. R., and WALLACE, M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 507–508.
   Google Scholar
• In vitro diffusion model predicting in vivo drug release from PLA microspheres injected in muscle tissue. Bromocriptine. ROHR, U. D., and WOLF, M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 506A–506B.
   Google Scholar
• An in vitro/in vivo correlation study of deposition of cyclosporin A from topical nonionic liposomes. NIEMIEC, S. M., Hu, Z., WALLACH, D. F. H., and WEINER, N., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 461–462.
   Google Scholar
• Liposomal polymyxin B: Characterization and pulmonary delivery. MCALLISTER, S. M., ALPAR, H. O., and BROWN, M. R. W., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 336–337.
   Google Scholar
• Oral delivery of calcitonin in rats and primates using proteinoid microspheres. SARUBBI, D., VARIANO, B., HAAS, S., MAHER, J., FALZARANO, L., BURNET, B., FULLER, G., SANTIAGO, N., MILSTEIN, S., et al. Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 288–289.
   Google Scholar
• Release properties of macromolecules from microspheres of a ABA triblock copolymer consisting of poly(lactic-co-glycolic acid) and polyoxyethylene. KISSEL, T., Li, Y. X., VOLLAND, C., and GOERICH, S., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 286–287.
   Google Scholar
• Liposome-mediated gene delivery:. Entry and intracellular trafficking of liposome plasmid DNA complexes. CONARY, J. T., SCHREIER, H., CANONICO, A. E., FAULKS, R. D., BRIGHAM, K. L., MAGUIRE, M., and EBNER, F., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 238–239.
   Google Scholar
• Vidarabine liposomal formulation: physicochemical characterization and pharmacological evaluation. CRUZ, M. E. M., BARBOSA, C. M., PoNzErro, A., and PRISTA, L. N., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 234–235.
   Google Scholar
• Binding of liposomal Glu-plasminogen to fibrin in vitro: comparison to and competition with free Glu-plasminogen. HEEREMANS, J. L. M., PREVOST, R., Los, P., KLUFT, C., and CROMMELIN, D. J. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 232-233. Tetracaine release profile from topical liposome formulation. NACUCCHIO, M., DI Rocco, P., LAIRION, F., MARTINEZ, B., and PENA, M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 230–231.
   Google Scholar
• Thermodynamic and kinetic aspects of the interaction of triamcinolone acetonide with liposomes. SCHREIER, H., Lc KYANOV, A. N., HOCHHAUS, G., and GONZALEZ, R. R. J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 228–229.
   Google Scholar
• Optimization of liposome formulation for the delivery of clodronate to cells in vivo. MONKKONEN, J., VALJAKKA, R., HAKASALO, M., and URTTI, A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 224–225.
   Google Scholar
• Delivery of cholesterol and porphyrins-derivatized antisense oligonucleotides to cells by liposomes and lipoproteins. LE DOAN, T., ETORE, F., MASTRUZZO, L., PITIE, M., LAURENT, M., TENU, J. P., DEBEY, P., LESNIK, P., and CHAPMAN, J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 220–221.
   Google Scholar
• Microencapsulated liposomes: lipid stability and influence of entrapped species. FEESER, T. M., and WHEATLEY, M. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 196–197.
   Google Scholar
• Indomethacin or progesterone loaded albumin and albumin linked with deoxycholate microspheres. ZECCHI, V., GIANASI, E., and ORIENTI, I., Proc. Int. Symp. Controlled Release Bioact. Mater., 1994, 21, 186–187.
   Google Scholar
• Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phos-phatidylethanolamine. RISIN, D., KLEINERMAN, E. S., UMEZU, Y., PIZZINI, R. P., BALCH, C. M., and PELL'S, N. R., Cancer Immunol. Immunother., 1995, 40, (1), 57–64.
   PubMedGoogle Scholar
• Studies on small ( 300 microns) microcapsules: II-Parameters governing the production of alginate beads by high voltage electrostatic pulses. HALLE, J. P., LEBLOND, F. A., PARISEAU, J. F., JUTRAS, P., BRABANT, M. J., and LEPAGE, Y., Cell Transplant, 1994, 3, (5), 365–372.
   Google Scholar
• Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. JAMES, N. D., CORER, R. J., TOMLINSON, D., HARRIS, J. R., GOMPELS, M., PINCHING, A., and STEWART, J. S., Clin. Oncol. (R. Coll. Radiol.), 1994, 6, (5), 294–296.
   PubMedGoogle Scholar
• Binding of fluorescent-labeled low molecular mass heparin to latex microspheres and to rat and human leukocytes. PIAZOLO, L., HARENBERG, J., MALSCH, R., and HEENE, D. L., Semin. Thromb. Hemost.,1994, 20, (3), 227–235.
   PubMedGoogle Scholar
• Characteristics of cytotoxic T lymphocytes directed to influenza virus haemagglutinin elicited by immunization muramyldipeptide-influenza liposome vaccine. IINumA, H., NEROME, K., YOSHIOKA, Y., and OKINAGA, K., Scand. .7. Immunol., 1995, 41, (1), 1–10.
   Google Scholar
• Bile salt secretion by hepatocytes incubated with bile salts and liposomes or low density lipoproteins. CI.ERC, T., SBARRA, V., BOTTA, F. D., LAFONT, H., PAR, L. P., GAUTHIER, A., and CHANUSSOT, F., Life Sci., 1994, 56, (4), 277–286.
   Google Scholar
• Acute toxicity and depression of phagocytosis in vivo by liposomes: influence of lysophos-phatidylcholine. LUTZ, J., AUGUSTIN, A. J., JAGER, L. ., BACHMANN, D., and BRANDI., M., Life Sci., 1994, 56, (2), 99–106.
   Google Scholar
• Phospholipase-C-promoted liposome fusion. GONI, F. NI., NIEVA, J. L., BASANEZ, G., FIDELIO, G., and Al.ONSO, A., Biochem. Soc. Trans., 1994, 22, (3), 839–844.
   Google Scholar
• Reconstruction of rat liver gap junctions into liposomes. DIEZ, J. A., and VILLALOBO, A., Biochem. Soc. Trans., 1994, 22, (3), 373S.
   Google Scholar
• Interaction of a peptide corresponding to the amino terminus region of the S protein of hepatitis B virus with liposomes. RODRIGUEZ, C. I., GOMEZ, G. J., PETERSON, D. L., and GAVI LANES, F., Biochem. Soc. Trans., 1994, 22, (3), 365S.
   PubMedGoogle Scholar
• A theoretical approach to polyhydroxy-mediated interactions between liposomes and bacterial biofilms. JONES, M. N., and KASZUBA, M., Biochem. Soc. Trans., 1994, 22, (3), 331S.
   PubMedGoogle Scholar
• Systemic targeting of liposome-encapsulated immunomodulators to macrophages for treatment of cancer metastasis. KILLION, J. J., and FIDLER, I. J., Immunomethods, 1994,4, (3), 273–279.
   PubMedGoogle Scholar
• Liposomes that provide T-dependent help to weak antigens (T-independent antigens). PIETROBON, P. J., GARCON, N., LEE, C. H., and Six, H. R., Immunomethods, 1994,4, (3), 236–243.
   Google Scholar
• Liposome-mediated cytoplasmic delivery of proteins: an effective means of accessing the MHC class I-restricted antigen presentation pathway. ZHOU, F., and HUANG, L., Immunomethods, 1994, 4, (3), 229–235.
   PubMedGoogle Scholar
• Endocytosis and presentation of liposome-associated antigens by B cells. GRIVEL, J. C., CROOK, K., and LESERMAN, L., Immunomethods, 1994, 4, (3), 223–228.
   PubMedGoogle Scholar
• Liposomes as carriers for vaccines. WASSEF, N. M., ALVING, C. R., and RICHARDS, R. L., Immunomethods, 1994, 4, (3), 217–222.
   Google Scholar
• Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment. GREGORIADIS, G., Immunomethods, 1994, 4, (3), 210–216.
   PubMedGoogle Scholar
• Liposomes for protein delivery: selecting manufacture and development processes. WEINER, A. L., Immunomethods, 1994, 4, (3), 201–209.
   PubMedGoogle Scholar
• Effect of 1-hydroxyethylidene-1,1-bisphosphonate on membrane-mediated calcium phos-phate formation in model liposomal suspensions. SKRTIC, D., and EANES, E. D., Bone Miner., 1994, 26, (3), 219–229.
   PubMedGoogle Scholar
• Liquid chromatography determination of liposome components using a light-scattering evaporative detector. JAASKELAI NEN, I., and URTTI, A.,1 Pharm. Biomed. Anal., 1994, 12, (8), 977–982.
   Google Scholar
• A rapid method for the separation and analysis of leaked and liposomal entrapped phosphoramide mustard in plasma. SRIGRITSANAPOL, A. A., and CHAN, K. K., Pharm. Biomed. Anal., 1994, 12, (8), 961–968.
   PubMedGoogle Scholar
• Gene therapy for brain tumors: cytokine gene therapy using DNA/liposome. OKADA, H., OKAMOTO, S., and YOSHIDA, J., No Shinkei Geka, 1994, 22, (11), 999–1004.
   PubMedGoogle Scholar
• Anti-hypertensive effect of oral controlled-release microspheres containing an ACE inhibitor (delapril hydrochloride) in rats. AKIYAMA, Y., YOSHIOKA, M., HORIBE, H., INADA, Y., HIRAI, S., KITAMORI, N., and TOGUCHI, H., y. Pharm. Pharmacol., 1994, 46, (8), 661–665.
   Google Scholar
• Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system. CRITCHLEY, H., DAVIS, S. S., FARRAJ, N. F., and ILLUM, L., 1. Pharm. Pharmacol., 1994, 46, (8), 651–656.
   Google Scholar
• The influence of surface properties on uptake of oil into complex coacervate microcapsules. RABISKOVA, M., SONG, J., OPAWALE, F. O., and BURGESS, D, J., j.Pharm. Pharmacol., 1994, 46, (8), 631–635.
   PubMedGoogle Scholar
• Fate and biocompatibility of three types of microspheres implanted into the brain. MENEI, P., CROUE, A., DANIEL, V., POUPLARD, B. A., and BENOIT, J. P., y. Biomed. Mater. Res., 1994, 28, (9), 1079–1085.
   Google Scholar
• A structure-function study of bovine pancreatic phospholipase A2 using polymerized mixed liposomes. DUA, R., Wu, S. K., and CH0, W., y. Biol. Chem., 1995, 270, (1), 263–268.
   PubMedGoogle Scholar
• Comparison of the toxicity of cinnamaldehyde when administered by microencapsulation in feed or by corn oil gavage. HEBERT, C. D., YUAN, J., and DIETER, M. P., Food Chem. Toxicol., 1994, 32, (12), 1107–1115.
   PubMedGoogle Scholar
• Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticu-loendothelial system uptake. ICA, K., OHKOUCHI, K., OGAWA, Y., and TOGUCHI, H., y. Drug Target., 1994, 2, (3), 259–267.
   PubMedGoogle Scholar
• Effect of liposome-muramyl tripeptide combined with recombinant canine granulocyte colony-stimulating factor on canine monocyte activity. KURZMAN, I. D., CHENG, H., and MACEWEN, E. G., Cancer Biother., 1994, 9, (2), 113–121.
   PubMedGoogle Scholar
• TLC-a rapid method for liposome characterization. BRAILOIU, E., SAILA, L., HUHUREZ, G., COSTULEANU, Ni., FILIPEANU, C. M., SLA'FINEANU, S., COTRUTZ, C., and BRANISTEANU, D. D., homed. Chromatogr., 1994, 8, (4), 193–195.
   PubMedGoogle Scholar
• Relapse of visceral leishmaniasis in patients who were coinfected with human im-munodeficiency virus and who received treatment with liposomal amphotericin B (letter). DAviosoN, R. N., and Russo, R., Clin. Infect. Dis., 1994, 19, (3), 560.
   PubMedGoogle Scholar
• Hydrolysis of DMPC or DPPC by pancreatic phospholipase A2 is slowed down when (perfluoroalkyl) alkans are incorporated into the liposomal membrane. PRIVITERA, N., NAON, R., and RIESS, J. G., Biochim. Biophys. Acta, 1995, 1254, (1), 1–6.
   PubMedGoogle Scholar
• Human 5-lipoxygenase associates with phosphatidylcholine liposomes and modulates LTA4 synthetase activity. NOGUCHI, Ni., MIYANO, M., MATSUMOTO, T., and NomA, Ni., Biochim. Biophys. Acta, 1994, 1215, (3), 300–306.
   PubMedGoogle Scholar
• Peroxidation of egg yolk phosphatidylcholine liposomes by hypochlorous acid. PANASENKO, O. NI., ARNHOLD, J., SCHILLER, J., ARNOLD, K., and SERGIENKO, V.., Biochim. Biophys. Acta, 1994, 1215, (3), 259–266.
   PubMedGoogle Scholar
• Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous Intralipid infusion. WASAN, K. M., GROSSIE, V. B. JR, and LoREz, B. G., Antimicrob. Agents Chemother., 1994, 38, (9), 2224–2226.
   PubMedGoogle Scholar
• Suppression of acute inflammation with liposome associated prostaglandin El. ROSSETTI, R. G., BRATHWAITE, K., and ZURIF:R, R. B., Prostaglandins, 1994, 48, (3), 187–195.
   PubMedGoogle Scholar
• Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer. SON, K., and HUANG, L., Proc. Natl. Acad. Sci. USA, 1994, 91, (26), 12669–12672.
   PubMedGoogle Scholar
• Antioxidant activity of alpha-tocopherol, beta-carotene, and ubiquinol in membranes: cis-parinaric acid-incorporated liposomes. TSUCHIYA, NI., KAC;AN, V. E., FREISLEBEN, H. J., MANABE, NI., and PACKER, L., Methods Enzymol., 1994, 234, 371–383.
   Google Scholar
• Gene transfer and the expression of a foreign gene in vivo in post-mitotic neurons of the adult rat brain using the hemagglutinating virus of the Japan-liposome method. KATO, K., YONEDA, Y., OKADA, Y., KIYAMA, H., and StnosARA, S., Brain Res. Mol. Brain Res., 1994, 25, (3-4), 359–363.
   PubMedGoogle Scholar
• Transbilayer diffusion of divalent cations into liposomes mediated by lipidic particles of phosphatidate. BAEZA, I., WONG, C., MONDRAGON, R., GONZALEZ, S., IBANEZ, NI., PARFAN, N., and ARGUELLO, C.J. Mo/. Eva, 1994, 39, (6), 560–568.
   PubMedGoogle Scholar
• Modeling degranulation with liposomes; effect of lipid composition on membrane fusion. BRocK, T. G., NAGAPRAKASH, K., MARGOLIS, D. I., and SMOLEN, J. E., g. Membr. Biol., 1994, 141, (2), 139–148.
   PubMedGoogle Scholar
• Simple method to prepare cationic multilamellar liposomes for efficient transfection of human interferon-beta gene to human glioma cells. YOSHIDA, J., and MIZUNO, NI., Neurooncol., 1994, 19, (3), 269–274.
   PubMedGoogle Scholar
• Laboratory evaluation of fenitrothion microcapsules as a new residual spraying formulation for mosquito control. KAWADA, H., OGAWA, NI., Proli, T., ABE, Y., Tsuji, K.,.7. Am. Mosq. Control Assoc., 1994, 10, (3), 385–389.
   Google Scholar
• An experimental study on a chemosensitivity test with alginate microcapsule. Feasibility of in vivo succinic dehydrogenase inhibition test. CHIN, K., SHIMIZU, K., and SHOJI, T., Nippon Ika, Daigaku Zasshi, 1994, 61, (5), 422–434.
   PubMedGoogle Scholar
• New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. STERNBERG, B., SORGI, F. L., and HUANG, L., FEBS Lett, 1994, 356, (2-3), 361–366.
   PubMedGoogle Scholar
• Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in mice. KEDAR, E., BRAUN, E., RUTKOWSKI, Y., EMANUEL, N., and BARENHOLZ, Y., y. Immunother. Emphasis Tumor Immunol., 1994, 16, (2), 115–124.
   PubMedGoogle Scholar
• Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid). FUJIMAKI, W., IToH, K., AN, T., GANO, J. B., Ross, M. I., MANSFIELD, P. F., BALCH, C. M., AUGUSTUS, L. B., KARKEVITCH, D. D., JOHNSTON, D. et at., Cancer Biother., 1993, 8, (4), 307–318.
   Google Scholar
• Mixing rates can markedly affect the kinetics of peptide-induced leakage from liposomes. POLOZOV, I. V., POLOZOVA, A. I., ANANTHARAMAIAH, G. M., SEGREST, J. P., EPAND, R. M., Biochem. Mol. Biol. Int., 1994, 33, (6), 1073–1079.
   PubMedGoogle Scholar